US Stock MarketDetailed Quotes
ICCC ImmuCell
- 3.580
- -0.030-0.83%
Close Nov 1 16:00 ET
- 3.580
- 0.0000.00%
Post 20:02 ET
28.04MMarket Cap-6884P/E (TTM)
3.650High3.560Low24.67KVolume3.560Open3.610Pre Close89.06KTurnover0.52%Turnover RatioLossP/E (Static)7.83MShares5.59052wk High1.20P/B16.87MFloat Cap3.34052wk Low--Dividend TTM4.71MShs Float13.200Historical High--Div YieldTTM2.49%Amplitude1.000Historical Low3.610Avg Price1Lot Size
About ImmuCell Company
ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.
Company Profile
SymbolICCC
Company NameImmuCell
Listing DateApr 1, 1987
Issue Price7.00
Founded1982
CEOMr. Michael F. Brigham
MarketNASDAQ
Employees79
Fiscal Year Ends12-31
Address56 Evergreen Drive
CityPortland
ProvinceMaine
CountryUnited States of America
Zip Code04103
Phone1-207-878-2770
Websitehttp://www.immucell.com
Company Executives
- Name
- Position
- Salary
- Michael F. Brigham
- President, Chief Executive Officer, Treasurer, Secretary, Principal Financial Officer and Director
- 395.24K
- Elizabeth Luttrell Williams
- Vice President, Manufacturing Operations
- 312.07K
- Bobbi Jo Brockmann
- Director and Vice President, Sales and Marketing
- 323.52K
- Dr. David S. Tohe, D.V.M.
- Chairman of the Board
- 42.00K
- Gloria J. Basse
- Independent Director
- 28.00K
- Steven T. Rosgen
- Independent Director
- 30.00K
- Paul R. Wainman
- Independent Director
- 30.00K
- Bryan K. Gathagan
- Independent Director
- 51.30K
- Elizabeth S. Toothaker
- Controller
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data